126 related articles for article (PubMed ID: 37738316)
21. Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
Greco FA; Gray J; Burris HA; Erland JB; Morrissey LH; Hainsworth JD
Cancer J; 2001; 7(3):203-12. PubMed ID: 11419028
[TBL] [Abstract][Full Text] [Related]
22. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
[TBL] [Abstract][Full Text] [Related]
23. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Ruiz de Porras V; Wang XC; Palomero L; Marin-Aguilera M; Solé-Blanch C; Indacochea A; Jimenez N; Bystrup S; Bakht M; Conteduca V; Piulats JM; Buisan O; Suarez JF; Pardo JC; Castro E; Olmos D; Beltran H; Mellado B; Martinez-Balibrea E; Font A; Aytes A
Eur Urol; 2021 Jun; 79(6):722-733. PubMed ID: 33153817
[TBL] [Abstract][Full Text] [Related]
24. Taxane-containing regimens for metastatic breast cancer.
Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
[TBL] [Abstract][Full Text] [Related]
25. Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer.
Horsell KW; Merten S; Clingan P; King DW; Morris DL
Aust N Z J Surg; 1999 Oct; 69(10):729-32. PubMed ID: 10527351
[TBL] [Abstract][Full Text] [Related]
26. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.
Brown J; Shvartsman HS; Deavers MT; Ramondetta LM; Burke TW; Munsell MF; Gershenson DM
Gynecol Oncol; 2005 May; 97(2):489-96. PubMed ID: 15863149
[TBL] [Abstract][Full Text] [Related]
27. Taxanes for adjuvant treatment of early breast cancer.
Ferguson T; Wilcken N; Vagg R; Ghersi D; Nowak AK
Cochrane Database Syst Rev; 2007 Oct; (4):CD004421. PubMed ID: 17943815
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer.
Raff JP; Rajdev L; Malik U; Novik Y; Manalo JM; Negassa A; Hopkins U; Sarta C; Sparano JA
Clin Breast Cancer; 2004 Feb; 4(6):420-7. PubMed ID: 15023243
[TBL] [Abstract][Full Text] [Related]
29. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
30. Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Réda M; Fouquier A; Desmoulins I; Mayeur D; Kaderbhai C; Ilie S; Hennequin A; Coudert B; Bertaut A; Ladoire S
Breast; 2023 Apr; 68():149-156. PubMed ID: 36773403
[TBL] [Abstract][Full Text] [Related]
31. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
Yardley DA
Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502
[TBL] [Abstract][Full Text] [Related]
32. Discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination.
Yan TD; Brun EA; Sugarbaker PH
Ann Surg Oncol; 2008 May; 15(5):1440-6. PubMed ID: 18299936
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features and predictors for survival of mucinous and non-mucinous appendiceal adenocarcinoma.
Hsu JT; Chen HM; Liao CH; Yeh CN; Yeh TS; Hwang TL; Jan YY; Chen MF
Dig Surg; 2008; 25(5):369-75. PubMed ID: 19005255
[TBL] [Abstract][Full Text] [Related]
34. Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
Surg Oncol; 2021 Mar; 36():120-129. PubMed ID: 33360118
[TBL] [Abstract][Full Text] [Related]
35. Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.
Shapiro JF; Chase JL; Wolff RA; Lambert LA; Mansfield PF; Overman MJ; Ohinata A; Liu J; Wang X; Eng C
Cancer; 2010 Jan; 116(2):316-22. PubMed ID: 19904805
[TBL] [Abstract][Full Text] [Related]
36. Cancer embryonic antigen (CEA) levels in patients with appendiceal adenocarcinoma predict response to neo-adjuvant chemotherapy and overall survival.
Egbert L; Norain A; Stucky CC; Ahmad S; Chang YH; Wasif N
J Surg Oncol; 2023 Mar; 127(4):688-698. PubMed ID: 36519637
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel and docetaxel in prostate cancer.
Obasaju C; Hudes GR
Hematol Oncol Clin North Am; 2001 Jun; 15(3):525-45. PubMed ID: 11525295
[TBL] [Abstract][Full Text] [Related]
38. Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study.
Rau KM; Lin YC; Chen YY; Chen JS; Lee KD; Wang CH; Chang HK
BMC Cancer; 2015 May; 15():423. PubMed ID: 25994543
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy.
Ung L; Chua TC; David L M
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1899-1908. PubMed ID: 24052322
[TBL] [Abstract][Full Text] [Related]
40. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
Morgan RB; Dhiman A; Sood D; Ong CT; Wu X; Shergill A; Polite B; Turaga KK; Eng OS
J Surg Oncol; 2023 Apr; 127(5):831-840. PubMed ID: 36636792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
